The F.D.A., and Alzheimer’s experts, emphasized that the blood test should be given only to people who are already experiencing cognitive decline and are ages 55 and older.

Overall, a blood test for Alzheimer’s disease, such as the one described in the new study, can be used to help diagnose both a person experiencing early memory loss, as well as before a patient ...

The blood-based test takes advantage of proprietary technology that makes it very sensitive to even low levels of the protein, which could make it a useful tool for screening for the disease.

A combined blood test for cognitive decline has a 90% accuracy rate in determining whether memory loss is due to Alzheimer’s disease, a new study found. In comparison, neurologists and other ...

Lab-developed blood tests have been used primarily by researchers, or by specialists in large medical centers. The test cleared by the FDA is likely to attract a much broader audience.

Why do we need a blood test for Alzheimer's? Alzheimer's disease is on the rise, in part because the age group most prone to dementia is growing larger. In the U.S., an estimated 7.2 million ...

To her surprise, the blood test — called Galleri — came back positive. Scans revealed a small tumor in her groin and a diagnosis of mantle cell lymphoma, a rare but aggressive form of cancer.

A blood test has been shown to detect Alzheimer’s disease in health care settings with up to 90% accuracy, as researchers presented at the Alzheimer’s Association International Conference.

Using this test, a fasting blood sugar level of 99 mg/dL or lower is considered normal, while 100 to 125 mg/dL indicates you have prediabetes, and 126 mg/dL or higher indicates you have diabetes.

If you could take a simple blood test that could detect multiple types of cancer while they’re still in an early and treatable stage, would you? For many, the answer would be a resounding yes ...

Alcediag hopes to alter this grim landscape. The company says its €900 (US$980) blood test, EDIT-B, can help to distinguish bipolar disorder from depression using biomarkers.